Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

Opioid Use Disorder: Barriers to Medicaid Beneficiaries' Access to Treatment Medications

  Premium   Download PDF Now (35 pages)
Report Type Reports and Testimonies
Report Date Jan. 24, 2020
Release Date Jan. 24, 2020
Report No. GAO-20-233
Summary:

Nearly 2 million Americans misused or were addicted to opioids in 2018. Medication-assisted treatment—which combines medications such as buprenorphine with behavioral therapy—can effectively treat opioid use disorders and overdoses.

Medicaid is one of the largest sources of coverage for individuals undergoing medication-assisted treatment. The Department of Health and Human Services has worked to increase access to the treatment.

We identified state policies that can restrict Medicaid beneficiaries’ access to medication-assisted treatments, and recommended that HHS ensure states comply with federal requirements to cover them.

Prescription bottles, pills, and a syringe with a needle

Prescription bottles, pills, and a syringe with a needle

« Return to search Government Accountability Office reports